13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q2 2024 · Filed August 9, 2024 · Accession 0000904454-24-000451
Total Value
$400.7M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $84.9M | 21.18% |
| 2 | Rapport Therapeutics, Inc. | RAPP | 2,498,051 | $58.1M | 14.50% |
| 3 | CVRx, Inc. | CVRX | 4,103,430 | $49.2M | 12.28% |
| 4 | Legend Biotech Corporation | LEGN | 814,586 | $36.1M | 9.00% |
| 5 | Contineum Therapeutics Inc. | CTNM | 1,979,173 | $34.9M | 8.70% |
| 6 | Nanobiotix S.A. | NBTX | 5,623,816 | $28.1M | 7.02% |
| 7 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $28.0M | 6.98% |
| 8 | Procept BioRobotics Corporation | PRCT | 357,939 | $21.9M | 5.46% |
| 9 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $18.2M | 4.54% |
| 10 | Xencor, Inc. | XNCR | 748,062 | $14.2M | 3.53% |
| 11 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $11.1M | 2.77% |
| 12 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $6.4M | 1.61% |
| 13 | Rallybio Corporation | RLYB | 3,636,363 | $4.9M | 1.22% |
| 14 | Nano-X Imaging Ltd. | NNOX | 158,852 | $1.2M | 0.29% |
| 15 | Vor Biopharma, Inc. | VOR | 1,074,658 | $1.1M | 0.27% |
| 16 | Aldeyra Therapeutics, Inc. | ALDX | 299,669 | $991,904 | 0.25% |
| 17 | BiomX Inc. | PHGE | 1,923,201 | $646,388 | 0.16% |
| 18 | Standard BioTools Inc | LAB | 311,967 | $552,182 | 0.14% |
| 19 | Adicet Bio, Inc. | ACET | 364,472 | $441,011 | 0.11% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $21,794 | 0.01% |